Shorepoint Capital Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $4.89M | Buy |
10,090
+280
| +3% | +$136K | 1.11% | 32 |
|
|
2024
Q4 | $3.95M | Buy |
9,810
+280
| +3% | +$113K | 0.9% | 40 |
|
|
2024
Q3 | $4.43M | Sell |
9,530
-44
| -0.5% | -$20.5K | 1.01% | 38 |
|
|
2024
Q2 | $4.49M | Buy |
9,574
+606
| +7% | +$284K | 1.05% | 36 |
|
|
2024
Q1 | $3.75M | Sell |
8,968
-162
| -2% | -$67.7K | 0.92% | 43 |
|
|
2023
Q4 | $3.71M | Buy |
9,130
+130
| +1% | +$52.9K | 1% | 41 |
|
|
2023
Q3 | $3.13M | Buy |
9,000
+466
| +5% | +$162K | 0.92% | 42 |
|
|
2023
Q2 | $3M | Buy |
8,534
+511
| +6% | +$180K | 0.85% | 42 |
|
|
2023
Q1 | $2.53M | Buy |
8,023
+773
| +11% | +$244K | 0.72% | 52 |
|
|
2022
Q4 | $2.09M | Buy |
+7,250
| New | +$2.09M | 0.58% | 58 |
|